News | September 04, 2024
Alkem signs license agreement with Takeda to commercialise Vonoprazan in India
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
The company recently received CEP certificate approval for Losartan Potassium by EDQM
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Subscribe To Our Newsletter & Stay Updated
